WO2002069984A3 - Utilisation d'uronides d'acide hyaluronique dans le cadre du traitement de processus inflammatoires - Google Patents

Utilisation d'uronides d'acide hyaluronique dans le cadre du traitement de processus inflammatoires Download PDF

Info

Publication number
WO2002069984A3
WO2002069984A3 PCT/DE2002/000688 DE0200688W WO02069984A3 WO 2002069984 A3 WO2002069984 A3 WO 2002069984A3 DE 0200688 W DE0200688 W DE 0200688W WO 02069984 A3 WO02069984 A3 WO 02069984A3
Authority
WO
WIPO (PCT)
Prior art keywords
uronides
treatment
hyaluronic acid
inflammatory processes
fostering
Prior art date
Application number
PCT/DE2002/000688
Other languages
German (de)
English (en)
Other versions
WO2002069984A2 (fr
Inventor
Peter-Juergen Mueller
Albert Haertl
Waltraud Hertel
Joerg-Hermann Ozegowski
Original Assignee
Knoell Hans Forschung Ev
Univ Schiller Jena
Peter-Juergen Mueller
Albert Haertl
Waltraud Hertel
Joerg-Hermann Ozegowski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoell Hans Forschung Ev, Univ Schiller Jena, Peter-Juergen Mueller, Albert Haertl, Waltraud Hertel, Joerg-Hermann Ozegowski filed Critical Knoell Hans Forschung Ev
Priority to EP02748304A priority Critical patent/EP1408990A2/fr
Publication of WO2002069984A2 publication Critical patent/WO2002069984A2/fr
Publication of WO2002069984A3 publication Critical patent/WO2002069984A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

La présente invention concerne l'utilisation intra-corporelle d'uronides d'acide hyaluronique de faible poids moléculaire et hautement actifs, obtenus par bio-ingénierie, dans le cadre du traitement de processus inflammatoires et de la promotion de la santé chez les êtres humains et les animaux.
PCT/DE2002/000688 2001-03-02 2002-02-21 Utilisation d'uronides d'acide hyaluronique dans le cadre du traitement de processus inflammatoires WO2002069984A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP02748304A EP1408990A2 (fr) 2001-03-02 2002-02-21 Utilisation d'uronides d'acide hyaluronique dans le cadre du traitement de processus inflammatoires

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10111165A DE10111165A1 (de) 2001-03-02 2001-03-02 Verwendung von Hyaluronsäure-Uroniden zur Behandlung von entzündlichen Vorgängen
DE10111165.7 2001-03-02

Publications (2)

Publication Number Publication Date
WO2002069984A2 WO2002069984A2 (fr) 2002-09-12
WO2002069984A3 true WO2002069984A3 (fr) 2003-01-30

Family

ID=7676737

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2002/000688 WO2002069984A2 (fr) 2001-03-02 2002-02-21 Utilisation d'uronides d'acide hyaluronique dans le cadre du traitement de processus inflammatoires

Country Status (3)

Country Link
EP (1) EP1408990A2 (fr)
DE (1) DE10111165A1 (fr)
WO (1) WO2002069984A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10352137A1 (de) 2003-11-04 2005-06-16 Beschorner, Katharina, Dr. Verwendung sulfatierter Hyaluronsäure
FR2919185B1 (fr) 2007-07-23 2010-09-10 Ard Sa Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses
CZ18797U1 (cs) 2008-07-08 2008-08-11 Isoline S.R.O. Prostredek k prevenci kloubních onemocnení
IT1391251B1 (it) * 2008-10-15 2011-12-01 Innovative Nutrition & Pharma Srl Composizione per il trattamento delle patologie articolari

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0243867A2 (fr) * 1986-04-28 1987-11-04 Mobay Corporation Compositions pour l'administration de l'acide hyaluronique à des mammifères
EP0295092A2 (fr) * 1987-06-12 1988-12-14 Unilever Plc Composition pour le traitement de la peau
JPH01151462A (ja) * 1987-12-09 1989-06-14 Terumo Corp 腹膜灌流液
JPH09241637A (ja) * 1996-03-14 1997-09-16 Chugai Pharmaceut Co Ltd 活性酸素ラジカル除去用組成物およびその方法
EP0888776A1 (fr) * 1996-03-15 1999-01-07 Takara Shuzo Co. Ltd. Produit obtenu par traitement thermique d'acide uronique, et aliments, boissons ou medicaments contenant ce produit
JPH11124401A (ja) * 1997-10-22 1999-05-11 Chisso Corp オリゴヒアルロン酸もしくはその塩の製造法
WO2000038647A1 (fr) * 1998-12-23 2000-07-06 Esparma Gmbh Agents pour proteger la peau, contenant un melange de fragments produit par hydrolyse a partir d'acide hyaluronique
WO2002032407A2 (fr) * 2000-10-19 2002-04-25 Hans-Knöll-Institut für Naturstoff-Forschung e.V. Utilisation de derives d'acide hyaluronique pour inhiber les arthrites inflammatoires
DE10053866A1 (de) * 2000-10-27 2002-05-08 Condomi Erfurt Produktions Gmb Bioverträgliche Flüssigformulierungen für human- und veterinärmedizinische Anwendungen als Gleitmittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4223613C2 (de) * 1992-07-17 1994-07-21 Zuckerindustrie Verein Verfahren zur Herstellung von ungesättigten Uroniden aus pektinhaltigen Stoffen

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0243867A2 (fr) * 1986-04-28 1987-11-04 Mobay Corporation Compositions pour l'administration de l'acide hyaluronique à des mammifères
EP0295092A2 (fr) * 1987-06-12 1988-12-14 Unilever Plc Composition pour le traitement de la peau
JPH01151462A (ja) * 1987-12-09 1989-06-14 Terumo Corp 腹膜灌流液
JPH09241637A (ja) * 1996-03-14 1997-09-16 Chugai Pharmaceut Co Ltd 活性酸素ラジカル除去用組成物およびその方法
EP0888776A1 (fr) * 1996-03-15 1999-01-07 Takara Shuzo Co. Ltd. Produit obtenu par traitement thermique d'acide uronique, et aliments, boissons ou medicaments contenant ce produit
JPH11124401A (ja) * 1997-10-22 1999-05-11 Chisso Corp オリゴヒアルロン酸もしくはその塩の製造法
WO2000038647A1 (fr) * 1998-12-23 2000-07-06 Esparma Gmbh Agents pour proteger la peau, contenant un melange de fragments produit par hydrolyse a partir d'acide hyaluronique
WO2002032407A2 (fr) * 2000-10-19 2002-04-25 Hans-Knöll-Institut für Naturstoff-Forschung e.V. Utilisation de derives d'acide hyaluronique pour inhiber les arthrites inflammatoires
DE10053866A1 (de) * 2000-10-27 2002-05-08 Condomi Erfurt Produktions Gmb Bioverträgliche Flüssigformulierungen für human- und veterinärmedizinische Anwendungen als Gleitmittel

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 199750, Derwent World Patents Index; AN 1997-539756, XP002210304, OKUBO KAZUYOSHI, YOSHIKI YUMIKO: "Composition for removing active oxygen free radical and removal thereof." *
DATABASE WPI Week 199929, Derwent World Patents Index; AN 1999-341642, XP002210303, SATO IKUO: "Production of oligo hyaluronic acid or salt thereof" *
PATENT ABSTRACTS OF JAPAN vol. 013, no. 414 (C - 635) 13 September 1989 (1989-09-13) *
PATENT ABSTRACTS OF JAPAN vol. 1998, no. 01 30 January 1998 (1998-01-30) *

Also Published As

Publication number Publication date
DE10111165A1 (de) 2002-10-10
EP1408990A2 (fr) 2004-04-21
WO2002069984A2 (fr) 2002-09-12

Similar Documents

Publication Publication Date Title
WO2003099771A3 (fr) Derives de diaryle-uree utilises pour le traitement des maladies dependant des proteines kinases
WO2005123116A3 (fr) Compositions et procedes pour le traitement ou la prevention de maladie liee a l'oxalate
WO2004010952A3 (fr) Procedes et compositions pour traiter des pathologies dermiques
WO2005055944A3 (fr) Composition d'oligosaccharides et leur utilisation dans le traitement d'infection
WO2006013441A3 (fr) Utilisation de bacteries probiotiques dans la preparation de compositions topiques destinees a la protection de la peau
AU2003220970A1 (en) Diamino-pyrimidines and their use as angiogenesis inhibitors
HK1087398A1 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
WO2005116088A3 (fr) Methodes et compositions pour traiter des maladies et des troubles associes a des cellules exprimant siglec-8
HK1067073A1 (en) Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
HK1096392A1 (en) Substituted heterocycles
WO2003096990A3 (fr) Cages proteiques pour l'administration d'agents therapeutiques et d'imagerie medicale
AU2001254624A1 (en) Human coagulation factor vii variants
WO2005082399A3 (fr) Traitement d'infections bacteriennes
HK1094320A1 (en) Antiseptic compositions, methods and systems
WO2007070052A3 (fr) Compositions pharmaceutiques et méthodes destinées à traiter ou prévenir une maladie associée à l'oxalate
IL169701A0 (en) The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
WO2004098536A3 (fr) Activite antivirale de peptides cathelicidiniques
EP1236465A3 (fr) Utilisation de produits de légumes pour traiter des atteintes extérieures
WO2002069984A3 (fr) Utilisation d'uronides d'acide hyaluronique dans le cadre du traitement de processus inflammatoires
WO2005077397A3 (fr) Procedes et compositions pour le traitement de maladies vasculaires
WO2003007876A3 (fr) Conjugues acide amine-acide gras normal et utilisations therapeutiques
WO2003024996A3 (fr) Macrocycles antibacteriens
WO2005011728A3 (fr) Utilisation de cd164 soluble pour les troubles inflammatoires ou auto-immuns
WO2003044047A3 (fr) Genes de virulence, proteines, et leurs utilisations
WO2005011611A3 (fr) Composes bicycliques et compositions utilisees comme inhibiteurs pdf

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AU BA BG BR CA CN CU CZ DZ EE GE HR HU ID IL IN IS JP KR LT MA MK MX NO NZ PL PT RO RU SD SG SI SK UA US YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AU BA BG BR CA CN CU CZ DZ EE GE HR HU ID IL IN IS JP KR LT MA MK MX NO NZ PL PT RO RU SD SG SI SK UA US YU ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

WWE Wipo information: entry into national phase

Ref document number: 2002748304

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002748304

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002748304

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP